Lomustine
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Lomustine".

content
Lomustine
Systematic (IUPAC) name
1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea
Identifiers
CAS number 13010-47-4
ATC code L01AD02
PubChem 3950
DrugBank APRD00292
Chemical data
Formula C9H16ClN3O2 
Mol. mass 233.695 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding 50%
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?
Legal status
Routes Oral

Lomustine (or "CCNU")(Marketed under the name CeeNU in US) is an alkylating nitrosourea compound used in chemotherapy. It is in the same family as streptozotocin. This is a highly lipid soluble drug, and thus crosses the blood brain barier. This property makes it ideal for treating brain tumors, and is its primary use. Lomustine has a long time to nadir (the time when white blood cells reach their lowest number).


Contents

Dose:

Adults: 100-150mg/m2 PO every 6 weeks (subsequent dose based on WBC) 1


Dosage Form:

10mg, 40mg, 100mg Capsules

Other

It is the "C" in the "PCV" chemotherapy regimen.

References

  1. ^ Lexi-Comp Drug Information Handbook

External links


Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
v • d • e
Chemotherapeutic agents/Antineoplastic agents (L01)
Purine+pyrimidine/
Ribonucleotides/
Deoxyribonucleotides
DNA
Other
Cellular
Other
Other/ungrouped
Other
© jGames.co.uk 2007 (some content from Wikipedia under GDL ) !-- ValueClick Media 468x60 and 728x90 Banner CODE for jgames.co.uk -->
Your Ad Here